Skip to Main Content

Author Details

Carl Koschmann
University of Michigan-Ann Arbor
2010
77
20
PMIDPaper TitleJournal TitlePublished Year
37723046Targeting DNA Repair and Survival Signaling in Diffuse Intrinsic Pontine Gliomas to Prevent Tumor Recurrence.Mol Cancer Ther2024
37723046Targeting DNA Repair and Survival Signaling in Diffuse Intrinsic Pontine Gliomas to Prevent Tumor Recurrence.Mol Cancer Ther2024
36335802The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science.Neoplasia2023
36335802The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science.Neoplasia2023
35605606Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma.Neuro Oncol2023
37584601Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.Cancer Discov2023
37647805Histone H3 K27M-mediated regulation of cancer cell stemness and differentiation in diffuse midline glioma.Neoplasia2023
37802053TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory.Cancer Cell2023
37552989Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid.Cell Rep Med2023
37149933Applying collaborative brain power to pull us out of the dark ages of pediatric neuro-oncology.Neoplasia2023
37145169ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma.Cancer Res2023
37398299H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Pediatric High-Grade Gliomas.bioRxiv2023
37195023ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma.Cancer Res2023
36685825Liquid biopsy in pediatric brain tumors.Front Genet2023
36724689Developing H3K27M mutant selective radiosensitization strategies in diffuse intrinsic pontine glioma.Neoplasia2023
37492101OpenPBTA: The Open Pediatric Brain Tumor Atlas.Cell Genom2023
37802053TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory.Cancer Cell2023
37552989Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid.Cell Rep Med2023
37584601Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.Cancer Discov2023
37647805Histone H3 K27M-mediated regulation of cancer cell stemness and differentiation in diffuse midline glioma.Neoplasia2023
37492101OpenPBTA: The Open Pediatric Brain Tumor Atlas.Cell Genom2023
35605606Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma.Neuro Oncol2023
37149933Applying collaborative brain power to pull us out of the dark ages of pediatric neuro-oncology.Neoplasia2023
37145169ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma.Cancer Res2023
37398299H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Pediatric High-Grade Gliomas.bioRxiv2023
37195023ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma.Cancer Res2023
36724689Developing H3K27M mutant selective radiosensitization strategies in diffuse intrinsic pontine glioma.Neoplasia2023
36685825Liquid biopsy in pediatric brain tumors.Front Genet2023
34668975Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry.Neuro Oncol2022
35464472Cell-Free Tumor DNA (cf-tDNA) Liquid Biopsy: Current Methods and Use in Brain Tumor Immunotherapy.Front Immunol2022
35840782Ultra-rapid somatic variant detection via real-time targeted amplicon sequencing.Commun Biol2022
35552452Characteristics of children ⿤36 months of age with DIPG: A report from the international DIPG registry.Neuro Oncol2022
35673129Expanding Access to CNS-TAP: Design, Development, and Initial Use of a Complex Precision Health Specialty Web App for Neuro-Oncology.Stud Health Technol Inform2022
36125896H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models.J Clin Invest2022
35978801Receptor tyrosine kinase (RTK) targeting in pediatric high-grade glioma and diffuse midline glioma: Pre-clinical models and precision medicine.Front Oncol2022
36382108Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy.Neurooncol Adv2022
36471067The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location.Nat Genet2022
34668975Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry.Neuro Oncol2022
35157764Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomas.Neuro Oncol2022
35137228Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma.Neuro Oncol2022
35323961Enhancing GD2 CAR T-cell therapy with IGF-1R blockade: Are DIPG CAR T cells ready for combinatorial therapy?Neuro Oncol2022
35840782Ultra-rapid somatic variant detection via real-time targeted amplicon sequencing.Commun Biol2022
35673129Expanding Access to CNS-TAP: Design, Development, and Initial Use of a Complex Precision Health Specialty Web App for Neuro-Oncology.Stud Health Technol Inform2022
35464472Cell-Free Tumor DNA (cf-tDNA) Liquid Biopsy: Current Methods and Use in Brain Tumor Immunotherapy.Front Immunol2022
35552452Characteristics of children ⿤36 months of age with DIPG: A report from the international DIPG registry.Neuro Oncol2022
36471067The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location.Nat Genet2022
36382108Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy.Neurooncol Adv2022
36125896H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models.J Clin Invest2022
35978801Receptor tyrosine kinase (RTK) targeting in pediatric high-grade glioma and diffuse midline glioma: Pre-clinical models and precision medicine.Front Oncol2022
35157764Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomas.Neuro Oncol2022
  • 1 - 50 of 154

Recommended Authors

Katherine E Miller
College of Medicine, The Ohio State University
Career Start Year 2017
Number of shared co-authors 4
David Pauck
German Cancer Research Center (DKFZ)
Career Start Year 2017
Number of shared co-authors 8
Chelsea Mayoh
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2016
Number of shared co-authors 28
Sebastian Brabetz
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2016
Number of shared co-authors 27
Juan C Vasquez
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Hiromichi Suzuki
Graduate School of Medicine, Kyoto University
Career Start Year 2012
Number of shared co-authors 18
Xin Wang
The Chinese University of Hong Kong, Prince of Wales Hospital
Career Start Year 2010
Number of shared co-authors 21
Felix Sahm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2010
Number of shared co-authors 46
Giles W Robinson
St. Jude Children's Research Hospital
Career Start Year 2010
Number of shared co-authors 42
Natalie J??ger
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2010
Number of shared co-authors 29
David J H Shih
University of Texas MD Anderson Cancer Center Houston
Career Start Year 2009
Number of shared co-authors 32
Kristian W Pajtler
Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University
Career Start Year 2009
Number of shared co-authors 49
Patricia Baxter
Texas Children's Cancer Center, Baylor College of Medicine
Career Start Year 2008
Number of shared co-authors 30
Claudia C Faria
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Career Start Year 2008
Number of shared co-authors 32
Adrian M Dubuc
Dana-Farber Cancer Institute
Career Start Year 2008
Number of shared co-authors 25
Dominik Sturm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2008
Number of shared co-authors 41
David Capper
Charite University Medicine Berlin
Career Start Year 2005
Number of shared co-authors 40
Eugene I Hwang
Children's National Hospital. Electronic address: .
Career Start Year 2004
Number of shared co-authors 47
Gelareh Zadeh
University of Toronto
Career Start Year 2003
Number of shared co-authors 37
Sheila K Singh
McMaster University
Career Start Year 2001
Number of shared co-authors 11
Brent A Orr
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 40
Till Milde
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 1998
Number of shared co-authors 37
Ghazaleh Tabatabai
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 1998
Number of shared co-authors 12
Vinay K Puduvalli
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 12
Michael D Taylor
The Hospital for Sick Children
Career Start Year 1995
Number of shared co-authors 65
Pim J French
Erasmus MC Cancer Institute
Career Start Year 1995
Number of shared co-authors 26
Erik P Sulman
NYU Grossman School of Medicine
Career Start Year 1995
Number of shared co-authors 20
Howard A Fine
Meyer Cancer Center
Career Start Year 1990
Number of shared co-authors 13
Annie Huang
Arthur and Sonia Labatt Brain Tumor Research Centre, Hospital for Sick Children
Career Start Year 1990
Number of shared co-authors 45
William A Weiss
University of California san francisco
Career Start Year 1985
Number of shared co-authors 36

Collaborators

Rajen Mody
Co-authored papers 23
Sriram Venneti
Co-authored papers 18
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers 15
Hugh J L Garton
Co-authored papers 13
Viveka Nand Yadav
Co-authored papers 12
Sabine Mueller
University Children's Hospital Zurich
Co-authored papers 12
Drew Pratt
Co-authored papers 9
Chandan Kumar-Sinha
Co-authored papers 8
Lili Zhao
Co-authored papers 8
Nicholas A Vitanza
Co-authored papers 8
Javad Nazarian
USA University of Zurich
Co-authored papers 8
Tingting Qin
Co-authored papers 7
Cassie Kline
Children's Hospital of Philadelphia
Co-authored papers 6
Daniel R Wahl
Co-authored papers 6
Matthew D Dun
Co-authored papers 6
Kathryn McFadden
Co-authored papers 6
Mariella G Filbin
Co-authored papers 6
Sharon L Gardner
Co-authored papers 5
Sebastian M Waszak
University of California san francisco
Co-authored papers 5
Alexander R Judkins
Co-authored papers 5
Sarah E S Leary
Co-authored papers 5
Jason E Cain
Co-authored papers 5
Pankaj Vats
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 4
David S Ziegler
Co-authored papers 4
Nicholas G Gottardo
Perth Children's Hospital
Co-authored papers 4
Rodrigo T Cartaxo
Co-authored papers 4
Xuhong Cao
Michigan Center for Translational Pathology.
Co-authored papers 4
Rishi R Lulla
Hasbro Children's Hospital, Brown University.
Co-authored papers 4
Debra Hawes
Co-authored papers 4
Adam C Resnick
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Co-authored papers 4
Release 1.2